Evaluation of Polycaprolactone/Gelatin/Chitosan Electrospun Membrane for Peritoneal Adhesion Reduction

2020 ◽  
Vol 84 ◽  
pp. S116-S122 ◽  
Author(s):  
Nan-Chieh Huang ◽  
Kai-Wen Teng ◽  
Nien-Chi Huang ◽  
Lan-Ya Kang ◽  
Keng-Yen Fu ◽  
...  
2021 ◽  
Vol 421 ◽  
pp. 129621
Author(s):  
Shengyang Zheng ◽  
Manhong Huang ◽  
Songmei Sun ◽  
Haitao Zhao ◽  
Lijun Meng ◽  
...  

2020 ◽  
Vol 44 (46) ◽  
pp. 20458-20469
Author(s):  
Jiaqi Chen ◽  
Chunhui Xiang ◽  
Nana He ◽  
Junhao Zhang ◽  
Lili Li ◽  
...  

The CS/PCL-(b-PEG) nanofibers with controllable core to shell ratio were fabricated as an adsorbent for dye adsorption.


2021 ◽  
pp. 088532822110081
Author(s):  
Shuo Zhang ◽  
Zhuoyue Xu ◽  
Xuejun Wen ◽  
Changzheng Wei

Peritoneal adhesion is one of the most common postsurgical complications and can cause bowel obstruction, pelvic pain, and infertility. Setting up a physical barrier directly between the injured site and surrounding tissues is an effective solution for preventing this adverse situation. This study investigated a chitosan electrospun membrane (CSEM) as a potent anti-adhesion barrier, which was prepared by a needleless technology called Nanospider. Scanning electron microscopy revealed that CSEM is a laminated nanofiber with good mechanical properties. The fiber is uniform with the diameter distributing in the range of 100–120 nm. The tensile strength can reach 27.45 ± 6.30 MPa with a maximum elongation at break of 18.50 ± 1.44%, which makes it stick easily to damaged parts but not to be easily damaged by tissue friction. The growth of S. aureus on CSEM was 59.18% lower than the control at 10 h, which indicates its better antibacterial property. In addition, CSEM has good coagulant and biocompatibility characteristics. It can perform hemostatic function within 10 min and the L929 mouse fibroblast viability on it was 92.18% ± 1.08% on the seventh day. In vivo experiments indicated that CSEM significantly prevented peritoneal adhesions within four weeks after surgery with wound surface coverage. These results indicate that CSEM is a promising anti-adhesion barrier material.


1994 ◽  
Vol 4 (1) ◽  
pp. 39-44
Author(s):  
Hassanean A.W. Aly ◽  
Emad Darwish ◽  
Doriya Bayomi ◽  
Omnia A. Nayel ◽  
Sayed A. Nayel ◽  
...  

2013 ◽  
Vol 52 (1) ◽  
pp. 113-122 ◽  
Author(s):  
Tiffany Davis Ling ◽  
Pinzhi Liu ◽  
Shangwu Xiong ◽  
Donald Grzina ◽  
Jian Cao ◽  
...  

2006 ◽  
Vol 2006 ◽  
pp. 1-4 ◽  
Author(s):  
Clara Di Filippo ◽  
Alessandro Falsetto ◽  
Vito De Pascale ◽  
Elisabetta Tufariello ◽  
Domenico De Lucia ◽  
...  

This study has evaluated whether systemic changes of plasminogen activator (t-PA) and plasminogen activator inhibitor-1 (PAI-1) parallel the adhesions development and whether they could be used as predictors of adhesion risk. This has been studied in an animal model of post-surgical peritoneal adhesion by monitoring for 10 days the plasma and tissue levels of t-PA and PAI-1. The results showed that both tissular and plasmatic levels of t-PA were decreased in concomitance with the development of peritoneal adhesions. In contrast, PAI-1 was found increased into the tissue and into the plasma samples of the rats taken at 5 and 10 days time points. Inflammatory mediators such as ICAM-1, VCAM-1, and IL-6 within the peritoneal lavage fluid also correlated with the adhesion formation process. In conclusion, post-surgical peritoneal adhesions provide alterations of local inflammatory components and local and systemic fibrinolytic components, possibly with PAI-1 quenching t-PA. This may have potential for the identification of high-risk patients.


Sign in / Sign up

Export Citation Format

Share Document